IL117816A0 - N-subsituted azaheterocyclic compounds their preparation and pharmaceutical compositions containing them - Google Patents

N-subsituted azaheterocyclic compounds their preparation and pharmaceutical compositions containing them

Info

Publication number
IL117816A0
IL117816A0 IL11781696A IL11781696A IL117816A0 IL 117816 A0 IL117816 A0 IL 117816A0 IL 11781696 A IL11781696 A IL 11781696A IL 11781696 A IL11781696 A IL 11781696A IL 117816 A0 IL117816 A0 IL 117816A0
Authority
IL
Israel
Prior art keywords
preparation
compositions containing
subsituted
pharmaceutical compositions
azaheterocyclic compounds
Prior art date
Application number
IL11781696A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL117816A0 publication Critical patent/IL117816A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL11781696A 1995-04-07 1996-04-03 N-subsituted azaheterocyclic compounds their preparation and pharmaceutical compositions containing them IL117816A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK40395 1995-04-07
DK100695 1995-09-11

Publications (1)

Publication Number Publication Date
IL117816A0 true IL117816A0 (en) 1996-08-04

Family

ID=26063927

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11781696A IL117816A0 (en) 1995-04-07 1996-04-03 N-subsituted azaheterocyclic compounds their preparation and pharmaceutical compositions containing them

Country Status (9)

Country Link
US (5) US5698551A (de)
EP (1) EP0820450B1 (de)
JP (1) JPH11503126A (de)
AT (1) ATE205489T1 (de)
AU (1) AU5100296A (de)
CA (1) CA2217206A1 (de)
DE (1) DE69615169D1 (de)
IL (1) IL117816A0 (de)
WO (1) WO1996031497A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952352A (en) * 1995-04-07 1999-09-14 Novo Nordisk A/S Heterocyclic compounds
AR015446A1 (es) * 1997-09-19 2001-05-02 Smithkline Beecham Corp Antagonistas de receptores de vitronectina, composicion farmaceutica que los contiene, procedimiento para su preparacion, su uso para la elaboracion de unmedicamento y compuestos intermediarios
US6576643B2 (en) 1997-09-19 2003-06-10 Smithkline Beecham Corporation Vitronectin receptor antagonists
WO1999047517A1 (en) * 1998-03-17 1999-09-23 Novo Nordisk A/S Novel heterocyclic compounds
US6214816B1 (en) 1998-03-17 2001-04-10 Novo Nordisk A/S Heterocyclic compounds
US6705675B1 (en) * 2000-05-08 2004-03-16 Graco Children's Products Inc. Adjustable child seat for toddlers to small children
US20040220167A1 (en) * 2003-05-02 2004-11-04 Nasrollah Samiy Methods of treating neuralgic pain
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
TW200615273A (en) * 2004-11-10 2006-05-16 Nicholas Piramal India Ltd Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
WO2006053273A2 (en) * 2004-11-12 2006-05-18 Alcon, Inc. Optical fiber detection method and system

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861987A (en) * 1955-12-28 1958-11-25 Cilag Ltd New diphenyl methane- and 1-aza-[2,3:5,6]-dibenzocy cloheptadiene derivatives, theiracid salts and quaternary salts and the production thereof
DE1084267B (de) * 1955-12-28 1960-06-30 Cilag Chemie Verfahren zur Herstellung von 1-Aza-[2, 3:5, 6]-dibenzocycloheptadien-derivaten, deren Salzen und quaternaeren Ammoniumverbindungen
FR145F (de) * 1964-06-01
US3336293A (en) * 1964-11-06 1967-08-15 Searle & Co Complex amides of 5, 6-dihydrophenanthridine-5-carboxylic acid, 5, 6-dihydro-11h-dibenz[b, e]azepine-5-carboxylic acid, and related compounds
US3514443A (en) * 1965-01-22 1970-05-26 Squibb & Sons Inc 5-(substituted amino-lower alkylene)-5,6-dihydrodibenz(b,f)azocines
US3803143A (en) * 1969-09-08 1974-04-09 Eisai Co Ltd 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines
JPS57106673A (en) * 1980-12-24 1982-07-02 Chugai Pharmaceut Co Ltd Dibenzo(b,f)(1,4)oxazepin derivative
GB2094790B (en) * 1981-03-13 1985-10-09 Spofa Vereinigte Pharma Werke Tricycle compounds
FR2512024A1 (fr) * 1981-08-27 1983-03-04 Adir Ethers tricycliques, leur preparation et les compositions pharmaceutiques les contenant
EP0332246A1 (de) * 1988-03-11 1989-09-13 Akzo N.V. Trizyklische Amin-Derivate
DK93791D0 (da) * 1991-05-17 1991-05-17 Novo Nordisk As Nye heterocykliske carboxylsyrer
GB9120640D0 (en) * 1991-09-27 1991-11-06 Ici Plc Tricyclic heterocycles
US5354747A (en) * 1993-06-16 1994-10-11 G. D. Searle & Co. 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use
MY113463A (en) * 1994-01-04 2002-03-30 Novo Nordisk As Novel heterocyclic compounds
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands

Also Published As

Publication number Publication date
CA2217206A1 (en) 1996-10-10
ATE205489T1 (de) 2001-09-15
EP0820450A1 (de) 1998-01-28
US5780486A (en) 1998-07-14
JPH11503126A (ja) 1999-03-23
US5698551A (en) 1997-12-16
EP0820450B1 (de) 2001-09-12
AU5100296A (en) 1996-10-23
DE69615169D1 (de) 2001-10-18
US5846968A (en) 1998-12-08
US5747481A (en) 1998-05-05
US5750518A (en) 1998-05-12
WO1996031497A1 (en) 1996-10-10

Similar Documents

Publication Publication Date Title
IL112222A (en) Pharmaceutical compositions containing n-substituted azaheterocyclic carboxylic acids and esters thereof certain such compounds and their preparation
MX9707531A (es) Nuevos compuestos heterociclicos.
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
PT1311285E (pt) Composicao farmaceutica liquida contendo um derivado de eritropoietina
DK0828724T3 (da) 5-oxygenerede diaryl-2-(5H)-furanoner som COX-2-inhibitorer
ATE232856T1 (de) Diaryl-2(5h)-fuaranone als cox-2-inhibitoren
NO20022442D0 (no) Legemidler for sykdommer i forbindelse med reduksjon i benmasse
IL117816A0 (en) N-subsituted azaheterocyclic compounds their preparation and pharmaceutical compositions containing them
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
ES2173858T3 (es) Analogos de huperzina a.
FI103116B1 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksi
IL117811A0 (en) N-substituted azaheterocyclic carboxylic compounds their preparation and pharmaceutical compositions containing them
IL117812A0 (en) N-substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
BG100246A (en) N-substituted azaheterocylic carboxylic acids and their esters
BR0214293A (pt) Composto e métodos para tratar um paciente que tenha, ou de prevenir um paciente de adquirir, uma doença ou condição e para produzir um composto ou um sal ou éster farmaceuticamente aceitável do mesmo
CA2301590A1 (en) 2-aminopyridines as inhibitors of cyclooxygenase-2
EA200500957A1 (ru) Применение l-допа, его производных и лекарственных средств, содержащих эти соединения, для профилактики психотических заболеваний
PL369845A1 (en) Use of 4-oxobutanoic acid derivatives in the treatment of inflammation